Table 3.
Patient’s disposition based on mortality.
| Alive | Dead | p value | |||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Sex | 0.294 | ||||
| Female | 96 | 66.7% | 48 | 33.3% | |
| Male | 136 | 61.3% | 86 | 38.7% | |
| Age | 0.001 | ||||
| <65 years old | 111 | 73.0% | 41 | 27.0% | |
| ≥65 years old | 121 | 56.5% | 93 | 43.5% | |
| Comorbidities before COVID-19 | |||||
| Chronic cardiopathy | 71 | 56.8% | 54 | 43.2% | 0.06 |
| Chronic pulmonary disease | 47 | 58.8% | 33 | 41.3% | 0.33 |
| Diabetes | 38 | 59.4% | 26 | 40.6% | 0.463 |
| Liver disease | 10 | 62.5% | 6 | 37.5% | 0.94 |
| Renal impairment | 7 | 26.9% | 16 | 61.5% | <0.001 |
| Obesity | 18 | 78.3% | 8 | 34.8% | 0.521 |
| Smoking history | 24 | 55.8% | 19 | 44.2% | 0.272 |
| No risk factor identified | 79 | 68.1% | 37 | 31.9% | 0.202 |
| Time last chemotherapy before COVID-19 | 0.658 | ||||
| In the last month | 158 | 62.0% | 97 | 38.0% | |
| In the last 3 months | 33 | 63.5% | 19 | 36.5% | |
| Chemotherapy ended > 3 months before COVID-19 | 39 | 68.4% | 18 | 31.6% | |
| Malignancy status at COVID-19 diagnosis | 0.003 | ||||
| Controlled disease | 146 | 68.5% | 67 | 31.5% | |
| Stable disease | 40 | 67.8% | 19 | 32.2% | |
| Active disease | 40 | 47.6% | 44 | 52.4% | |